Avoro Capital Advisors’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-430,000
| Closed | -$9.87M | – | 43 |
|
|
2018
Q3 | $9.87M | Sell |
430,000
-2,370,191
| -85% | -$54.4M | 0.45% | 30 |
|
|
2018
Q2 | $53.3M | Buy |
2,800,191
+25,000
| +0.9% | +$476K | 2.05% | 18 |
|
|
2018
Q1 | $46.8M | Buy |
2,775,191
+1,366,245
| +97% | +$23M | 2.23% | 19 |
|
|
2017
Q4 | $21.4M | Buy |
1,408,946
+420,676
| +43% | +$6.39M | 1.39% | 21 |
|
|
2017
Q3 | $17.7M | Buy |
988,270
+86,124
| +10% | +$1.54M | 1.37% | 21 |
|
|
2017
Q2 | $14.7M | Buy |
902,146
+284,946
| +46% | +$4.64M | 1.86% | 16 |
|
|
2017
Q1 | $8.64M | Buy |
617,200
+235,734
| +62% | +$3.3M | 1.1% | 23 |
|
|
2016
Q4 | $6.08M | Sell |
381,466
-446,227
| -54% | -$7.12M | 1.23% | 24 |
|
|
2016
Q3 | $13.8M | Buy |
827,693
+118,114
| +17% | +$1.97M | 2.42% | 15 |
|
|
2016
Q2 | $7.94M | Sell |
709,579
-145,000
| -17% | -$1.62M | 1.76% | 20 |
|
|
2016
Q1 | $7.14M | Sell |
854,579
-406,230
| -32% | -$3.4M | 2.49% | 14 |
|
|
2015
Q4 | $11.7M | Sell |
1,260,809
-863,784
| -41% | -$8.04M | 4.04% | 9 |
|
|
2015
Q3 | $24M | Buy |
2,124,593
+685,900
| +48% | +$7.74M | 6.23% | 3 |
|
|
2015
Q2 | $18.3M | Buy |
+1,438,693
| New | +$18.3M | 5.03% | 8 |
|